Registration open for workshop on access to clinical-trial data and transparency
The European Medicines Agency is inviting expressions of interest in its workshop on access to clinical-trial data and transparency on 22 November 2012.
The workshop follows the Agency’s decision to proactively publish clinical-trial data and enable access to full data sets by interested parties.
It is intended to elicit the views, interests, and concerns from a broad range of institutions, groups and individuals. Results from the workshop will help the Agency define the modalities of proactive access to clinical trial data, in a way that best serves patients and public health in an open and transparent forum.
Expressions of interest should be sent to email@example.com by 31 October 2012. Places are limited to 150 and will be offered on a first-come-first-served basis.
- Workshop on access to clinical trial data and transparency (22/11/2012)
- European regulators propose way forward for publication of full clinical trial data (11/04/2012)
- Transparency policy